Alberto Gallardo

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 11

Top Topics

Neoadjuvant Chemotherapy

Top Venues

International journal of molecular sciences

Diagnostics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Anna C Virgili, Juliana Salazar, Alberto Gallardo, Antonio López-Pousa, Raúl Terés, Silvia Bagué, Ruth Orellana, Caterina Fumagalli, Ramón Mangues, Lorena Alba-Castellón, Ugutz Unzueta, Isolda Casanova, Ana Sebio
CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas. Diagnostics (Basel, Switzerland) 14 (11) (2024)
Cristina Arqueros, Alberto Gallardo, Silvia Vidal, Ruben Osuna-Gómez, Ariadna Tibau, Olga Lidia Bell, Teresa Ramon Y Cajal, Enrique Lerma, Barbara Lobato-Delgado, Juliana Salazar, Agusti Barnadas
Clinical Relevance of Tumour-Infiltrating Immune Cells in HER2-Negative Breast Cancer Treated with Neoadjuvant Therapy. International journal of molecular sciences 25 (5) (2024)
Anna C Virgili, Juliana Salazar, Alberto Gallardo, Antonio López-Pousa, Raúl Terés, Silvia Bagué, Ruth Orellana, Caterina Fumagalli, Ramón Mangues, Lorena Alba-Castellón, Ugutz Unzueta, Isolda Casanova, Ana Sebio
CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas. Diagnostics (Basel, Switzerland) 14 (11) (2024)
Cristina Arqueros, Alberto Gallardo, Silvia Vidal, Ruben Osuna-Gómez, Ariadna Tibau, Olga Lidia Bell, Teresa Ramon Y Cajal, Enrique Lerma, Barbara Lobato-Delgado, Juliana Salazar, Agusti Barnadas
Clinical Relevance of Tumour-Infiltrating Immune Cells in HER2-Negative Breast Cancer Treated with Neoadjuvant Therapy. International journal of molecular sciences 25 (5) (2024)
Cristina Arqueros, Alberto Gallardo, Silvia Vidal, Ruben Osuna-Gómez, Ariadna Tibau, Olga Lidia Bell, Teresa Ramon Y Cajal, Enrique Lerma, Barbara Lobato-Delgado, Juliana Salazar, Agusti Barnadas
Clinical Relevance of Tumour-Infiltrating Immune Cells in HER2-Negative Breast Cancer Treated with Neoadjuvant Therapy. International journal of molecular sciences 25 (5) (2024)
Cristina Arqueros, Juliana Salazar, Alberto Gallardo, Marta Andrés, Ariadna Tibau, Olga Lidia Bell, Alícia Artigas, Adriana Lasa, Teresa Ramon Y Cajal, Enrique Lerma, Agustí Barnadas
Secreted Protein Acidic and Rich in Cysteine ( SPARC) Polymorphisms in Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer Patients. Biomedicines 11 (12) (2023)
Yáiza Núñez, Annabel Garcia-León, Aïda Falgàs, Naroa Serna, Laura Sánchez-García, Ana Garrido, Jorge Sierra, Alberto Gallardo, Ugutz Unzueta, Esther Vazquez, Antonio Villaverde, Ramón Mangues, Isolda Casanova
T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo. Pharmaceutics 15 (3) (2023)
Yáiza Núñez, Annabel Garcia-León, Aïda Falgàs, Naroa Serna, Laura Sánchez-García, Ana Garrido, Jorge Sierra, Alberto Gallardo, Ugutz Unzueta, Esther Vazquez, Antonio Villaverde, Ramón Mangues, Isolda Casanova
T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo. Pharmaceutics 15 (3) (2023)
Yáiza Núñez, Annabel Garcia-León, Aïda Falgàs, Naroa Serna, Laura Sánchez-García, Ana Garrido, Jorge Sierra, Alberto Gallardo, Ugutz Unzueta, Esther Vazquez, Antonio Villaverde, Ramón Mangues, Isolda Casanova
T22-PE24-H6 Nanotoxin Selectively Kills CXCR4-High Expressing AML Patient Cells In Vitro and Potently Blocks Dissemination In Vivo. Pharmaceutics 15 (3) (2023)
Cristina Arqueros, Juliana Salazar, Alberto Gallardo, Marta Andrés, Ariadna Tibau, Olga Lidia Bell, Alícia Artigas, Adriana Lasa, Teresa Ramon Y Cajal, Enrique Lerma, Agustí Barnadas
Secreted Protein Acidic and Rich in Cysteine ( SPARC) Polymorphisms in Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer Patients. Biomedicines 11 (12) (2023)
Alberto Gallardo, Barbara Garcia-Valdecasas, Paola Murata, Rolando Teran, Laura Lopez, Agusti Barnadas, Enrique Lerma
Inverse relationship between Ki67 and survival in early luminal breast cancer: confirmation in a multivariate analysis. Breast cancer research and treatment 167 (1) (2017)